EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS133-08920 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr13:114301130-114302950 
Target genes
Number: 9             
NameEnsembl ID
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
E2F6MA0471.1chr13:114302067-114302078CTTTCCCGCCC-6.32
NR2C2MA0504.1chr13:114301751-114301766TCACCTCTGACCTCT-6.88
NR2C2MA0504.1chr13:114301758-114301773TGACCTCTGACCTTC-7.33
Nr2f6MA0677.1chr13:114301758-114301772TGACCTCTGACCTT-7.28
RxraMA0512.2chr13:114301758-114301772TGACCTCTGACCTT-6.62
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_41872chr13:114301246-114302949LNCaP
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr13114301674114302571
chr13114301802114302224
Number: 2             
IDChromosomeStartEnd
GH13I113646chr13114300486114301165
GH13I113647chr13114301216114302896
Enhancer Sequence
TAGAAGGTAT GAAGGAGAGC TAAGTGTTTT ATTTGAGTTG GCTAAATCAA TCACTGAAAA 60
TTCCAATAGA AGACTAGTTT TAGAAGAATC ATTTTTTCCT AATCTTGAAT TACCATAAGC 120
ATATCGAGGG TTGTGGAACT TACATAAAAC TACGGGCAGT CGTGCCTCAG AGGGCTCTGT 180
GTGGGTGCAT GTGCAGCCAG CACCTGCGGG TGCACCGTGG CTTCCCGTGG CGAGCTTCCT 240
GTGCCTGTGT TTCTTCCAGG CCTTGGGGGT TGAAACTCAG GGCTGGTGAT TCTGAAGGGT 300
GGGGCAGGAG CAGCCCCCGG CTTTATCAGG AAGGGGCTCT GATCGGGCAC GGGGGTGCCC 360
CTGTGGGTGG GATTGCTGGA GCCCAGGACA TCAAGGCCAG CCTGGGCAGC ATAGAGAGAC 420
CCTGCCTCTG AAGAAAGAGT GGGGCTCTGG TGTCCATGGA GAGTCTGGGG AGGGAGGAAG 480
AGGCTAGGGT TCTGAGGGCC TGGAGATGGG GGCTCTGGGT GGCCATGGGA CACGTGGCAG 540
GCGTGTTGGG TTCCAGCTGG GTTGGCTTTG AGAGTCTGGT GGGATGAACC CTCATGGCTC 600
CACCGTCACT TTGAGGTGGT GTCACCTCTG ACCTCTGACC TTCAGCATGG CATGACCTCG 660
CTGAGGTGAC CCTGGTGTCC CACATATCAC CCTGAGTGTT CTTAATACAC AGTCGAGGGC 720
TGTGTTCATT GGACTATTCT GGTGTCACCG CCCACTTCAT TTCTGTGCCT GGCAGCACTT 780
TTACTCCTGG TTGGGAGCAT GACCGCCTCC CAGTTCAGCT TCCTCCTGCG TCCCAAGTGA 840
GCGGGGCGGC TGTCCTCGAG GACTCCGGGC TCACAGCCAA CCTGCTGGCA CGGCTCGAGG 900
ACTCCGGGCT CACAGCCAAC CTGCTGGCAC GGCCGCCCTT TCCCGCCCTG CCTCGGGTGA 960
GCCAAGGACT TGTCTTCTGC TTCCTGGGTT CCTGAAAGAG CTCTCCTCTG ATTTCTCAAA 1020
GGCAAAATAA AACTCAGATT TAAGTCTTTG GTGCGTAGCC CCTAATTTCC TTCCCTTTCT 1080
CTGAATCCTC ACTGCCCAGC ATGATGGACC GGCCTGGGCT CAGGACCTGA TTCCACAGGC 1140
TCCCAGCCCT CCCACAGGTA CCGTGTCTTC TGTGCTGGTG TCGCACCCGC CGGCCACCGC 1200
CACCCTGCGT CTTAGACGTC CCGCCGCAGC TGTGTTTCCA CCTCATCTCC AGCTTGAGTG 1260
GCAGCCAGCG GCGCCACCTG CACACGAGCC CCCTCCATTC GAGAAGCACA GACTATGAGT 1320
GTGGCCACGC GTCCCATGAC GTGAACTCAC GTCTGCGCCG AGACCTTTGC CGGCGGTTTT 1380
TTACTGACGG AGTAAGCACT GGAGATGCTT GGTACAGCGT CTTCCATCGG TAAATTGATT 1440
TAGTTAACCT TACAACATAT CTGCAAGGTT TTTAATCTTT CTTCCAAGAC CGTTTCTCAT 1500
GGACTTTTCT GTGTGTCTGT TGGGGGCTGA CGGACTTCGA CGCGCCAGTC GCTTGTGCTT 1560
GGGGCCCTTT GGGTACTAAC AGCCACACTG CTGAGCATGT GAAATCAGGA CCCAGGCTGC 1620
ACACCGCCGT CGGGGTGAGA CGCCCGTGGC CTTGCATGAT GAAACTGGGA CCCAGGCCTC 1680
ACTGCTGTCT GGGTGAGAAG TCTGTGGCCT TCAGCAAGAG CAGGTTTGCT TGTTTGGGAG 1740
AATGTTCTCA TTTCAGTTTT TTGAAAGGGT TAGAGCTGCT AACTTAACAT TTATATTTGG 1800
AGGAGAGACT TGTTCTTGGT 1820